Plenary: Friday Morning
Friday, May 15, 2026 7:30 AM to 11:45 AM · 4 hr. 15 min. (America/New_York)
Hall D
Plenary
Plenary: Friday Morning
Survivor Debate: How Do We Best Assess Prostate Cancer Patients on Active Surveillance for Disease Progression?
Friday, May 15, 2026 7:35 AM to 8:05 AM
Hall D
Philip Dundee · Department of Urology, The Royal Melbourne Hospital
Mark Emberton · University College London
Laurence Klotz · Sunnybrook Health Sciences Centre
Wayne Brisbane · UCLA Health
Crossfire: Controversies in Urology: Management of de Novo M1A PSMA-Pet Scan Positive Prostate Cancer
Friday, May 15, 2026 8:05 AM to 8:45 AM
Hall D
Scott Delacroix · Mary Bird Perkins Cancer Center
Robert Karnes · Mayo Clinic
Alicia Morgans · Harvard Medical School
Tyler Seibert · University of California San Diego
Daniel Spratt · UH Seidman Cancer Center/Case Western
AUA-EAU Guidelines Panel Discussion: A Case-based Comparison of the Advanced Prostate Cancer Guidelines
Friday, May 15, 2026 8:45 AM to 9:15 AM
Hall D
Kristen Scarpato · Vanderbilt University Medical Center
Alice Yu · Moffitt Cancer Center
Giorgio Gandaglia · UniSR
Chad Ritch · Cleveland Clinic Florida
Derya Tilki · Martini-Klinik Prostate Cancer Center
Crossfire: Controversies in Urology: Bladder Preservation After Neoadjuvant Chemotherapy with Next Generation Treatments: Can Cystectomy be Avoided?
Friday, May 15, 2026 9:15 AM to 9:45 AM
Hall D
Shilpa Gupta · Cleveland Clinic Foundation
Ashish Kamat · MD Anderson Cancer Center
Amy Luckenbaugh · Vanderbilt University Medical Center
Shahrokh Shariat · Medical university of Vienna
Alejandro Rodriguez · Wake Forest University School of Medicine - Atrium Health Wake Forest Baptist Medical Center
Ramon Guiteras Lecture: What Urologists Have Taught Us About Screening & Incidental Detection in Cancer (or at least, what they’ve taught me)
Friday, May 15, 2026 9:45 AM to 10:30 AM
Hall D
H. Gilbert Welch
P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: Durvalumab with bacillus Calmette–Guérin therapy for high-risk non-muscle-invasive bladder cancer: expanded efficacy and safety analyses from POTOMAC
Friday, May 15, 2026 10:30 AM to 10:40 AM
Hall D
Neal Shore · Carolina Urologic Research Center
P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: Topline Results From PIVOT-006- A Phase 3, Randomized Controlled Study of Adjuvant Intravesical Cretostimogene Grenadenorepvec versus Surveillance for Intermediate-Risk Non-Muscle Invas
Friday, May 15, 2026 10:40 AM to 10:50 AM
Hall D
Max Kates · Johns Hopkins
P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: A non-viral intravesical gene therapy for BCG-unresponsive NMIBC with CIS, with or without papillary disease: pivotal phase 2 interim results of detalimogene voraplasmid
Friday, May 15, 2026 10:50 AM to 11:00 AM
Hall D
Ashish Kamat · MD Anderson Cancer Center
P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: Intravenous Pembrolizumab Combined with Intravesical Bacillus Calmette–Guérin (BCG) for Patients with BCG-Naïve “Very High-Risk” T1 Non-Muscle Invasive Bladder Cancer Traditionally Reco
Friday, May 15, 2026 11:00 AM to 11:10 AM
Hall D
Eugene Pietzak · Memorial Sloan Kettering Cancer Center
P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: Darolutamide plus androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC): ARASEC – US prospective, open-label phase 2 study with an external control
Friday, May 15, 2026 11:10 AM to 11:20 AM
Hall D
Rana Mckay · UCSD
P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: Long-Term Oncological Outcomes of Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-Risk Prostate Cancer: Phase 3 Randomized C
Friday, May 15, 2026 11:20 AM to 11:30 AM
Hall D
Jean Felipe Lestingi
P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: Extended follow-up shows accumulating benefit for patients treated with CAN-2409+prodrug in combination with standard of care external beam radiation (EBRT) in men with localized prosta
Friday, May 15, 2026 11:30 AM to 11:40 AM
Hall D
Mark Garzotto · Oregon Health & Science University
